EDMONTON, ALBERTA (September 25, 2020) – 48Hour Discovery Inc. announced today that it has filed a US provisional patent that describes a novel method for...

Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley, to expand their technology into...

A University of Alberta spinoff company is adding their cutting-edge technology to the search for antiviral compounds to treat individuals infected with COVID-19. 48Hour...

48Hour Discovery Inc. announced today that it has initiated drug discovery projects for therapeutic targets related to COVID-19. 48Hour Discovery Inc. is using its proprietary technology...

New technology platform would deliver orally available small molecule therapeutics for a wide range of targets EDMONTON, ALBERTA (April 18, 2019) – 48Hour Discovery (48HD)...

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) – Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision”...

EDMONTON, ALBERTA (April 15, 2019) – 48Hour Discovery INC., a biotechnology company focused on the discovery of peptide-derived small molecule therapeutics, is pleased to welcome Dr....

EDMONTON, ALBERTA (March 11, 2019) – 48Hour Discovery Inc. announced the appointment of David Alton as the Director of Business Development, effective March 11, 2019....

EDMONTON (April 17 2018)–48Hour Discovery Inc. (48HD) is pleased to announce a sponsorship with the Canadian Glycomics Network (GlycoNet) to support the Canadian Glycomics...

Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting new technology and will involve...